Metraipolis › archive › dc_4d50019edbee

Protocol summary and statistical analysis plan for the bone loss prevention with zoledronic acid or denosumab in critically ill adults (BONE ZONE) trial — Europe PMC PMID:41940313

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41940313
DOI
10.1016/j.ccrj.2026.100173
License (as archived)
solo-consultazione
Archived
2026-11-03T23:53:28.920Z
SHA-256 of the archived text
96b257a360eddd41a027384e273de47535360acc5f0717f11c08819949f80992
Stable URL of this page
https://metraipolis.com/documento/dc_4d50019edbee

How to cite

Protocol summary and statistical analysis plan for the bone loss prevention with zoledronic acid or denosumab in critically ill adults (BONE ZONE) trial — Europe PMC PMID:41940313 — Europe PMC (en), https://europepmc.org/article/MED/41940313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d50019edbee (Metraipolis archive dc_4d50019edbee, sha256 96b257a360eddd41a027384e273de47535360acc5f0717f11c08819949f80992)
BibTeX
@misc{dc4d50019edbee,
  title = {Protocol summary and statistical analysis plan for the bone loss prevention with zoledronic acid or denosumab in critically ill adults (BONE ZONE) trial — Europe PMC PMID:41940313},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41940313},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d50019edbee; sha256 96b257a360eddd41a027384e273de47535360acc5f0717f11c08819949f80992},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41940313. Agents can read the archived copy with the MCP tool read_document.